Revenue (Quarterly) Chart

View Revenue (Quarterly) for HYPD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 0.3577M
March 31, 2026 0.2443M
December 31, 2025 0.4962M
September 30, 2025 0.3025M
June 30, 2025 0.00
March 31, 2025 0.0147M
December 31, 2024 0.0281M
September 30, 2024 0.0016M
June 30, 2024 0.0226M
March 31, 2024 0.005M
December 31, 2023 0.0026M
September 30, 2023 0.0012M
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 10.00M
Date Value
September 30, 2021 0.00
June 30, 2021 2.00M
March 31, 2021 2.00M
December 31, 2020 2.00M
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Omeros Corp. 28.53M
Talphera, Inc. 0.00
ANI Pharmaceuticals, Inc. 266.04M
Corcept Therapeutics, Inc. 256.15M
Veru, Inc. 0.00

Revenue (Quarterly) Related Metrics